Clinical Trial

Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma

Study acronym: PREFER
Recruiting
View on ClinicalTrials.gov →
Summary
Aim of this prospective multicenter study is to evaluate the safety of an endoscopic follow-up strategy in patients treated with endoscopic resection (ER) for submucosal or high-risk mucosal esophageal adenocarcinoma (T1bN0M0 or HR T1aN0M0 EAC).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2017-07-18; most recent amendment 2024-07-23.
Trial Details
NCT Number NCT03222635
Lead Sponsor Amsterdam UMC
Conditions Submucosal Esophageal Adenocarcinoma, Barrett Esophagus, High-risk Mucosal Esophageal Adenocarcinoma
Enrollment 225 participants
Start Date 2017-07-25
Primary Completion 2028-07-25 (estimated)
Study Completion 2028-07-25 (estimated)
Updated on ClinicalTrials.gov 2024-07-24